GADPHARM LTD

💤Zombieactive
SC442597 · ltd · incorporated 2013-02-12
Investment thesis
Zombie company — trading but stalled; unlikely mover.
Why interesting: Quiet, steady; could be a succession or carve-out candidate with the right conversation.
Why risky: No growth signal; thin margin for error on price.
🔒Estimated value
Upgrade to see
Turnover
year to Feb 2025
Net worth
£3.8k
book net assets
Opportunity
78/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Dispensing chemist in specialised stores
Sector: Wholesale & retail
Investor take
Pursue
Asset-holding vehicle with a 72-year-old founder — textbook succession opportunity.

Opportunity 78/100 (strong), bankability 75/100. Strong seller-intent signal (68/100, director aged 72). Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (73/100).

Data confidence

Overall: medium (78/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
1 officers (1 active, 1 linked, 1 with DOB)
90
Ownership & PSC
1 active PSC(s) of 1 total, 1 with control declared
90
Director network
Network not yet resolved
30
Filing history
30 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
78/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
70
Active, clean filings, stable charge profile.
Acquirability
70
Strong succession / seller-readiness signals.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · accounting standard not declared
Positive net assets
Net assets £3,831

Key financials

2 years extracted from filed iXBRL accounts
Cash
Net Worth
£4k
↑ 80% YoY
Current Assets
£1k
↓ 38% YoY
Current Liabilities
£0£766£2k£2k£3k£4kFeb 2024Feb 2025

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · accounting standard unknown
Metric2025-02-282024-02-28
Total assets£2.4k£418
Current assets£1.1k£1.7k
Net assets£3.8k£2.1k

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

Recent activity

Last 30 days
0
filings
Last 90 days
4
filings
  • 2 officers
  • 1 confirmation-statement
  • 1 persons-with-significant-control
Last 180 days
5
filings
  • 2 officers
  • 1 confirmation-statement
  • 1 persons-with-significant-control
Counts from Companies House filing history.
Corporate timeline (17 events)Click to expand
  1. 2026-02-21
    📄
    change-person-director-company-with-change-date
    officers · CH01
  2. 2026-02-21
    📄
    change-person-director-company-with-change-date
    officers · CH01
  3. 2026-02-21
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  4. 2025-11-28
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  5. 2024-11-30
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  6. 2023-11-30
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  7. 2022-11-22
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  8. 2021-11-29
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  9. 2021-02-08
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  10. 2019-11-28
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  11. 2018-12-07
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  12. 2018-11-28
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  13. 2017-11-30
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  14. 2016-11-30
    📄
    accounts-with-accounts-type-total-exemption-small
    accounts · AA
  15. 2016-03-31
    📄
    annual-return-company-with-made-up-date-full-list-shareholders
    annual-return · AR01
  16. 2013-02-12
    🏢
    Company incorporated
    As GADPHARM LTD
  17. 2013-02-12
    GADSDEN, Paul Martin appointed
    director

Owner dependency

95/100
Critical — business is the founder

The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.

FACTORS
  • +Sole director: Only one active director — all governance concentrated on one person.
  • +Founder age: Director aged approximately 72 — succession pressure is live.
  • +No director turnover: Company is 13 years old with no director changes — suggests a very tight-knit founder team never broadened.

Succession & seller-readiness

88/100
Likely off-market candidate

Strong acquirability signals converging. Worth approaching directly — this is how off-market deals start.

SIGNALS
  • primaryFounder aged 70+: Senior director is approximately 72 years old. Natural succession window is now.
  • primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
  • secondary12+ year tenure: Director in role 13 years.
  • supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

1 active beneficial owner
NameSharesVoting rightsNature of controlNotified
Mr Paul Martin Gadsden
Individual · British · DOB 09/1954 · age 72
sig. influencesignificant influence12/02/2017

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

Similar companies

Active · Retail · IV postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
CFUK CONCEPTS LTD
SC496696 · est 2015 · no financials extracted
11y
CROWN STORES LTD
SC353985 · est 2009 · no financials extracted
17y
ELGIN FURNITURE & CARPET CENTRE LIMITED
SC252844 · est 2003 · no financials extracted
22y
FLOCK & SAUNTER LTD
SC863222 · est 2025 · no financials extracted
GALE TRADING LIMITED
SC872202 · est 2025 · no financials extracted
GARDENS AND GIFTS LIMITED
SC834783 · est 2025 · no financials extracted
1y
GRACE LILY LINGERIE LIMITED
SC489814 · est 2014 · no financials extracted
11y
GREENS PETALS & BLOOMS LTD
SC883593 · est 2026 · no financials extracted
GUR WINE AND SPIRITS BUSINESS CONSULTANCY LIMITED
SC605503 · est 2018 · no financials extracted
7y
H & M HYDRAULICS (ELGIN) LTD
SC414812 · est 2012 · no financials extracted
14y
HIGHLAND HI FI LTD
SC510133 · est 2015 · no financials extracted
10y
HIGHLAND HOSTS LIMITED
SC842888 · est 2025 · no financials extracted
1y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2013-02-12
Jurisdictionscotland
Primary SIC47730 — Dispensing chemist in specialised stores

Registered office

Firview Muir Of Balnagowan
Ardersier
Inverness
Scotland
IV2 7QX
United Kingdom

Filing status

Accounts
Next due: 2026-11-30
Last made up to: 2025-02-28
Confirmation statement
Next due: 2027-02-26
Last: 2026-02-12

Officers (1 active · 0 resigned)

GADSDEN, Paul Martin
director · ~72y · appointed 2013-02-12
View their other companies + combined net worth →
Active

Click a director name to see their full track record across all companies.

Recent filings (30 total)

confirmation-statement-with-no-updates
confirmation-statement · CS01
2026-02-24
change-person-director-company-with-change-date
officers · CH01
2026-02-21
change-person-director-company-with-change-date
officers · CH01
2026-02-21
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2026-02-21
accounts-with-accounts-type-micro-entity
accounts · AA
2025-11-28
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-02-20
accounts-with-accounts-type-micro-entity
accounts · AA
2024-11-30
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-03-04
accounts-with-accounts-type-micro-entity
accounts · AA
2023-11-30
confirmation-statement-with-no-updates
confirmation-statement · CS01
2023-03-13
accounts-with-accounts-type-micro-entity
accounts · AA
2022-11-22
confirmation-statement-with-no-updates
confirmation-statement · CS01
2022-03-30
accounts-with-accounts-type-micro-entity
accounts · AA
2021-11-29
confirmation-statement-with-no-updates
confirmation-statement · CS01
2021-03-26
accounts-with-accounts-type-micro-entity
accounts · AA
2021-02-08